Page 7 - மோர்கன் ஸ்டான்லி ஆசியா வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange CAMBRIDGE, Mass. and SUZHOU, China, Dec. 17, 2020 /PRNewswire/ HBM Holdings Limited ( Harbour BioMed , HBM or the Company ; Stock Code: 02142.HK), a global clinical-stage biopharmaceutical company, completed its global offering (the Global Offering ) and its listing on the Main Board of the Stock Exchange of Hong Kong Limited (the Stock Exchange ). The number of offer shares under the Global Offering is a total of 138,221,000 shares at a price of HK $12.38 per share, raising HK$1,711 million (USD$221 million) in total (before exercise of the over-allotment option in connection with the Global Offering). The offering was completed on December 10

United statesHong kongDistrict of columbiaUnited kingdomUnited kingdom generalJingsong wangAnlan fundMorgan stanley asiaCapital marketsChina international capital corporation hong kong securitiesBlackrock fundCredit suisse hong kongMerrill lynch far eastHong kong stock exchangeHoldings limited the company in hong kongOrbimed fund